Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07367867
Eligibility Criteria:
Inclusion Criteria:
The following inclusion criteria will be considered in the adult cohort:
* Adults over 18 years
* Signed informed consent
* HIV diagnosis confirmed by the Public Health Institute
* Patients under clinical control in any of the participating centers
* Availability to attend the taking of samples and medical controls
The following inclusion criteria will be considered in the pediatric cohort:
* Infants and children younger 18 years
* Patients under control in any of the participating center
* Signed informed consent by parents or legal guardians of the minor. In children 8 years and older, also informed assent
* In infants under 4 months of life, HIV diagnosis by a first positive RT-PCR for HIV performed at the Public Health Institute. In infants and children over 4 months, HIV diagnosis is confirmed by the Public Health Institute.
* Children exposed to HIV during pregnancy, labor or breastfeeding of mothers with confirmed HIV, with a negative diagnosis.
* Availability to attend the taking of samples and medical controls, and without medical contraindications for taking the samples (severe anemia according to age).
The following exclusion criteria will be considered in both cohorts:
\- The only exclusion criterion will be the patient's refusal to participate in the case of adults and in the case of minors, the non-signature of the informed consent by the legal guardians and the minor's non-assent.
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT07367867
Study Brief:
Protocol Section:
NCT07367867